NCT07412379

Brief Summary

Introduction: Human life expectancy has increased significantly, leading to a transformation in the global demographic structure. Cancer is considerably more common among older adults compared to younger populations, as age is one of the main risk factors for its development. In fact, most solid tumors are considered age-related diseases. For this reason, the incidence of cancer among older individuals is expected to continue rising. Oncological care for this population group is particularly complex and represents a significant challenge, as comorbidities and the social aspects of aging create clinical scenarios that differ greatly from those seen in younger patients. Objective: To identify the predictive factors of functional decline and quality of life at 12 months of follow-up, as well as oncological outcomes at 5 years of follow-up, in patients aged 65 years and older with gastrointestinal cancer who undergo curative-intent resective surgery at Hospital Universitario Mayor - Méderi, Bogotá, Colombia. Methodology: Longitudinal and analytical observational study of prospective prognostic cohort type. Expected Results: Predictive model of functional decline and quality of life, as well as oncological outcomes, in patients with gastrointestinal cancer undergoing curative-intent surgical procedures.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
327

participants targeted

Target at P75+ for all trials

Timeline
43mo left

Started Jan 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Jan 2026Dec 2029

Study Start

First participant enrolled

January 13, 2026

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

February 9, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 17, 2026

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2029

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2029

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

3.2 years

First QC Date

February 9, 2026

Last Update Submit

February 9, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Predictive factors associated with functional and quality of life decline at 12 months

    Factors associated with functional and quality of life decline at 12 months follow-up

    12 months

  • Predictive factors associated with oncological outcomes

    Predictive factors associated with oncological outcomes

    5 years

Secondary Outcomes (8)

  • Population characterization

    5 years

  • Surgical and functional outcomes

    1 year

  • Oncological outcomes

    5 years

  • Comparison

    1 year

  • Qualitative evaluation

    1 year

  • +3 more secondary outcomes

Study Arms (1)

Patients aged over 65 years with a gastrointestinal tract cancer diagnosis

Patients aged over 65 years with a gastrointestinal tract cancer diagnosis that are taken to surgery with a curative intent.

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients ≥65 years of age with a gastrointestinal tract cancer diagnosis taken to surgery with a curative intent in the Hospital Universitario Mayor - Méderi, Bogotá, Colombia.

You may qualify if:

  • Gastrointestinal cancer tract diagnosis (oesophagus, stomach, duodenum, pancreas, liver, biliary tract, small bowel, appendix, colon and rectum)
  • Have resectable disease by surgery
  • Taken to surgery by curative intent
  • Willingness to participate and enrollment by informed consent
  • Attended in the Mederi Hospital Networn

You may not qualify if:

  • Mortality
  • Loss to follow-up
  • Not taken to surgery
  • Emergency surgery
  • Taken to surgery as an oncological relapse or due to complications previous to an index procedure
  • Endoscopical treatment
  • Second primary tumor without a minimum 5 year disease free period from the primary one
  • Basal functionality 0/6 by Katz score.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Mayor-Méderi

Bogotá, Colombia

RECRUITING

Central Study Contacts

Camilo Ramírez-Giraldo, Surgeon

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 9, 2026

First Posted

February 17, 2026

Study Start

January 13, 2026

Primary Completion (Estimated)

March 31, 2029

Study Completion (Estimated)

December 15, 2029

Last Updated

February 17, 2026

Record last verified: 2026-02

Locations